-+ 0.00%
-+ 0.00%
-+ 0.00%

Alpha Tau Sets Nov. 16 Call to Review Interim Glioblastoma Trial Results

PUBT·11/12/2026 13:33:38
Listen to the news
Alpha Tau Sets Nov. 16 Call to Review Interim Glioblastoma Trial Results
  • Alpha Tau will review new interim REGAIN trial results on Nov. 16, 2026, at 8:30 a.m. ET.
  • The U.S. multicenter trial evaluates Alpha DaRT radiation therapy in patients with recurrent glioblastoma.
  • Results will be presented at the Society for Neuro-Oncology meeting, scheduled for Nov. 12-15, 2026, in Philadelphia.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Tau Medical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-118478), on November 12, 2026, and is solely responsible for the information contained therein.